ランキングに戻る

Ingersoll Rand Inc (IR)

適正価値
IndustrialsSpecialty Industrial MachineryUnited States

ファンダメンタル

72

株価

$75.11

時価総額

$29.64B

パート1 · 企業の価値

概要

Ingersoll Rand Inc. provides mission-critical air, fluid, clean energy, and medical technologies services and solutions worldwide. It operates in two segments, Industrial Technologies and Services, and Precision and Science Technologies. The Industrial Technologies and Services segment designs, manufactures, markets, and services a range of air and gas compression and treatment equipment, vacuum and blower products, fluid transfer equipment, loading systems, and power tools and lifting equipment; and other specialized equipment, including aftermarket parts, consumables and services, air treatment equipment, controls, other accessories, and services under the Ingersoll Rand, Gardner Denver, Nash, CompAir, Elmo Rietschle, and other brands. The Precision and Science Technologies segment designs, manufactures, and markets diaphragm, piston, water-powered, peristaltic, gear, vane, progressive cavity, and syringe pumps; and gas boosters, hydrogen compression systems, liquid handling systems, odorant injection systems, controls, software, and other related components and accessories for precision dosing, liquid and solid transfer, dispensing, gas compression and sampling, pressure management, flow control, powder handling, and other applications under the Air Dimensions, Albin, ARO, Dosatron, Haskel, Ingersoll Rand, LMI, Maximus, Milton Roy, MP, Oberdorfer, Seepex, Thomas, Welch, Williams, YZ, and Zinnser Analytic brands. This segment's products are used in medical, laboratory, industrial manufacturing, water and wastewater, chemical processing, clean energy, food and beverage, agriculture and other markets. It sells its products through a network of direct sales representatives and independent distributors. It has a strategic alliance with Garrett Motion. The company was formerly known as Gardner Denver Holdings, Inc. and changed its name to Ingersoll Rand Inc. in March 2020. Ingersoll Rand Inc. was founded in 1859 and is headquartered in Davidson, North Carolina.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

Compare

Generated on 2026年9月18日 with claude-haiku-4-5 — shared with all users

P/E: 32.8Score: 79Market cap: $17.04B

IDEX competes with Ingersoll Rand in both of its segments, selling industrial pumps and fluid-handling equipment as well as precision dosing and metering pumps for life sciences and medical applications.

P/E: 22.5Score: 68Market cap: $25.79B

Dover's pump and fluid-transfer businesses compete with Ingersoll Rand's Precision and Science Technologies segment for the same customers in industrial dosing, biopharma and medical fluid handling.

P/E: 24.2Score: 72Market cap: $12.67B

Graco makes fluid-handling pumps and dispensing equipment, and Ingersoll Rand lists it as a primary competitor for the precision pump and metering customers served by its Precision and Science Technologies segment.

Atlas Copco ABNot tracked

Atlas Copco is the world's largest maker of industrial air compressors, vacuum pumps and blowers and meets Ingersoll Rand head-on in the same factories and plants that buy compressed-air systems and their aftermarket service.

Kaeser Kompressoren SENot tracked

Kaeser is a privately held German manufacturer of rotary-screw compressors and blowers sold to the same industrial customers, and Ingersoll Rand names it as a principal competitor in its compression business.

Flowserve CorporationFLS

Flowserve supplies industrial pumps and flow-control equipment to the same process, chemical and energy plants that buy Ingersoll Rand's compression and fluid-handling products, including the aftermarket parts and service that follow.

貸借対照表と流動性

売上高

$7.94B

直近12か月(2026/6/30まで)

純利益

$959M

直近12か月(2026/6/30まで)

フリーキャッシュフロー

$1.22B

自己資本合計

$10.09B

負債合計

$8.14B

流動比率

1.62

利払い倍率

5.58

負債/EBITDA

2.93

一株当たり利益(EPS)

売上高と純利益

フリーキャッシュフロー

収益内訳

財務推移表

利益率の推移

負債の推移

負債の重さ

成長率グリッド

成長率 — 売上高

適正価値の推定

一般的なケース適正価値

適正価値

$62.83

現在株価

$75.11

安全マージン

-19.5%

適正価値レンジ

$40.84 - $84.83

使用した評価手法間のばらつきであり、統計的に較正された信頼区間ではありません。

推定方法

アナリストの目標株価:$96.25
ディスカウンテッド・キャッシュフロー(DCF):$53.85
利益倍率(P/E):$47.17
グレアムの成長公式:$39.40
収益力価値(EPV):$26.57
正当化されたP/B:$20.43
配当割引モデル(ゴードン):$1.21
P/FFO(運用から生まれる資金):$44.83
中間サイクル利益:$48.81
売上高倍率:$57.63
アナリスト・コンセンサス:買い (14B / 9H / 0S)
直近の決算サプライズ:+0.77%

バリュエーション指標

P/E レシオ

30.91

ROE

5.8%

P/B レシオ

2.86

P/FCF

23.90

粗利益率

42.8%

ROIC

7.3%

収益性レーダー

価値創造(経済的モート)

ROIC

7.3%

WACC

10.0%

ROIC − WACC

-2.6 pp

ROICが資本コストを下回っています。投資した1ドルごとに企業は価値を破壊しています。

ファンダメンタル分析基準

合格(21)

  • EPS shows upward trend
  • Price CAGR 8.87%
  • ROIC 7.3%
  • Gross Margin 42.8%
  • P/FCF 23.90
  • P/B Ratio 2.86
  • Debt/Equity ratio
  • Operating Margin 18.1%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • ROE 9.5%
  • Revenue Growth 5Y 14.0%
  • Analyst Consensus 61% Buy
  • Earnings Quality (OCF/NI) 1.41
  • Share Dilution -1.5%
  • Net Margin Trend 12.1% vs 7.1%
  • Piotroski F-Score 5/9

不合格(4)

  • Low reliance on intangibles
  • Price below Graham Number
  • DCF valuation (Overvalued)
  • Earnings Surprise avg -0.1%

データなし(2)

  • Dividend Payout NaN%
  • PEG Ratio (need PE > 0 and growth > 0)

Piotroski F-スコア

5/9

まちまちのシグナル:一部の領域に注意が必要

score
criteria

利益の質

1.41

高品質:利益はキャッシュに裏付けられている

株式希薄化

-1.5%

株式を買い戻している。株主に友好的

機関投資家の保有

ガバナンス

経営陣

氏名役職年齢
Mr. Vicente ReynalChairman, CEO & President50
Mr. Vikram U. KiniSenior VP & CFO44
Mr. Andrew R. Schiesl Esq.Senior VP, General Counsel, Chief Compliance Officer & Secretary53
Ms. Kathleen M. KeeneSenior VP & Chief Human Resources Officer50
Mr. Michael A. WeatherredSenior Vice President of Ingersoll Rand Execution Excellence (IRX), Business & Commercial Excellence63
Mr. Michael J. ScheskeVP & Chief Accounting Officer37
Mr. Matthew J. EmmerichSenior VP & Chief Information Officer49
Mr. Matthew FortVP of Investor Relations, Global Financial Planning & Analysis-
Ms. Elizabeth Meloy HepdingSenior Vice President of Corporate Development47
Mr. Arnold LiSenior VP & President of ITS Asia Pacific-

監査リスク

5

取締役会リスク

7

報酬リスク

3

株主権利リスク

5

パート2 · 株価と買い時

この部分は企業に価値があるかを判断するものではありません。ファンダメンタルズに納得したうえで、いつ買うかを選ぶためのものです。内容:テクニカル分析、ポテンシャル、過去のドローダウン、ガンマエクスポージャー。

書類

  • 年次報告書(10-K)

    事業内容、財務実績、リスクをまとめた年次の概要。

    提出日: 2026-02-17

    書類を見る
  • 四半期報告書(10-Q)

    直近3か月間の業績に関する最新情報。

    提出日: 2026-07-31

    書類を見る
  • 臨時報告書(8-K)

    経営陣の交代や重要な発表など、大きな出来事に関するお知らせ。

    提出日: 2026-07-30

    書類を見る

via SEC EDGAR

業績推移

via SEC EDGAR

Latest News

Recent headlines for IR, sourced from Markets Gazette.

No recent news for IR.